In conclusion, zinc administration in COVID-19 patients can influence the immune system positively by correcting any underlying zinc deficiency; and potentially negatively in zinc-replete patients by interfering with interferon lambda response, causing cytotoxicity to T and B cells and impairing TLR-4-mediated dendritic cell maturation. The gene discussed is TLR4; the disease is COVID-19.